accordance with Joint Accreditation criteria, the Association of Diabetes Care
& Education Specialists (ADCES) must ensure that anyone in a position to
control the content of the educational activity (planners and
speakers/authors/discussants/moderators) has disclosed all relevant financial
relationships with any commercial interest.
Joint Accreditation also requires that
ADCES manage any reported conflict and eliminate the potential for bias during
the educational activity. Any conflicts noted below have been managed to our
satisfaction. The disclosure information is intended to identify any commercial
relationships and allow learners to form their own judgments. However, if you
perceive a bias during an activity, please report it on the evaluation.
Relevant disclosures (or lack thereof)
among educational activity planners and faculty are as follows:
Dawn Noe, RDN, LD, CDCES - has no relevant financial disclosures to report.
Julia Blanchette, PhD, RN, CDCES - Insulet Corporation. Tandem Diabetes; Speaker, Presenter, Consultant, Independent Contractor/Pump Trainer, Independent Contractor/Pump Trainer
Jodi Lavin-Tompkins, MSN, RN, CDCES,
BC-ADM, has no relevant financial disclosures to report.
Joanne Rinker, MS, RDN, CDCES, LDN, FADCES, has no relevant financial disclosures to report.
Bau Tran, MMS, PA-C, PharmD, FCCP, PA and Pharmacy Planner Shivajirao Prakash Patil, MD, MPH, BC-ADM, FAAFP, MD Planner, - Novo Nordisk, Clinical Trial Research grant- ended in April 2020
The approval of this educational
offering by the ADCES does not imply endorsement of specific therapies,
treatments, or products discussed in the presentations.
Disclosure of Relevant Financial
Relationships and Mechanism to Identify and Resolved Conflicts of
Undertaking review of the educational
activity to evaluate for potential bias, balance in presentation,
evidence-based content or other indicators of integrity, and absence of